CHM 6.25% 1.7¢ chimeric therapeutics limited

Ann: Clinical milestones for 2024 & 2023 successes highlighted, page-4

  1. 1,852 Posts.
    lightbulb Created with Sketch. 33
    there’s so much potential here - incredible programs and the 3 step out plans (which will take some time to build and complete) are the holy grail - the science does seem compelling. A nice early deal with BP will help with one or more of these and kick along the progression. I keep adding …
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.